Investor attention around Madison Square Garden Entertainment (MSGE) has picked up as the New York Knicks' NBA Finals run focuses the spotlight on MSG linked stocks and possible future moves such as spin offs and overseas growth.

The recent Knicks spotlight and Penn Station redevelopment agreement sit alongside a 30 day share price return of 10.91% and a year to date share price return of 33.22%. The 1 year total shareholder return of 92.02% and 3 year total shareholder return of 94.02% indicate stronger gains over a longer holding period.

If this kind of momentum has your attention, it could be a good moment to see what else is moving and scan 20 top founder-led companies

With MSGE trading at $72.39, sitting about 5.5% below the average analyst price target and roughly 11% below one estimate of intrinsic value, you have to ask: is there still a buying opportunity here, or is the market already pricing in future growth?

Most Popular Narrative: 5.2% Undervalued

On the most followed narrative, Madison Square Garden Entertainment's fair value of $76.38 sits a little above the last close at $72.39. This puts the focus on whether the event pipeline can support that gap.

Sustained strong demand for live events and premium in-person experiences is translating into record ticket sales and advance bookings for fiscal '26, with concerts and special events at both the Garden and theaters pacing ahead of prior years, this growth in volume and pricing is likely to drive meaningful increases in revenue and operating income.

Read the complete narrative. Read the complete narrative.

Want to see what is baked into that fair value beyond the headline Knicks buzz and summer concert calendar? The narrative leans on compounded revenue growth, a sharp step up in margins and a richer earnings base several years out. All of this is run through a specific discount rate and future P/E that differ from where the stock sits today. The tension between those inputs and the current price is where the real story gets interesting.

Result: Fair Value of $76.38 (UNDERVALUED)

However, there is still meaningful execution risk, especially if concert volumes soften or consumer spending on premium hospitality and ticketing weakens from current levels.

Another Lens On Value: Earnings Multiple vs Peers

Our DCF model suggests MSGE is trading about 10.8% below an estimated fair value of $81.19, which points to an undervalued setup. However, the current P/E of 69.9x tells a different story when set against the US Entertainment industry at 26x and a fair ratio of 32.4x. Is the market paying up for future earnings growth, or simply stretching the risk on this story?

For a closer look at how this cash flow view is built, and where the assumptions might feel either conservative or punchy, it helps to walk through the full model inputs and sensitivities, especially if you are weighing DCF against headline multiples like P/E. Look into how the SWS DCF model arrives at its fair value.

Next Steps

With sentiment clearly split between optimism on growth and caution on execution, it makes sense to move quickly and test the assumptions against your own expectations by reviewing the 2 key rewards and 3 important warning signs 2 key rewards and 3 important warning signs

Looking for more investment ideas?

If MSGE has sharpened your interest, do not stop here. Use the screener tools to quickly surface other stocks that might fit your approach.

• Target dependable cash generation by scanning companies in the solid balance sheet and fundamentals stocks screener (46 results) that can help anchor the risk side of your portfolio.
• Hunt for potential mispricings with the screener containing 21 high quality undiscovered gems and spot stocks the broader market might not be focusing on yet.
• Stack the odds with quality and value by running the 46 high quality undervalued stocks so you have a shortlist ready before the next big move.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.